VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival

Surgery

Volumn 139, Issue 6, 2006, Pages 839-846

  Schoppmann, Sebastian F ^a   Fenzl, Alexandra ^a   Nagy, Katalin ^a   Unger, Sandra ^a   Bayer, Guenther ^a   Geleff, Silvana ^a   Gnant, Michael ^a   Horvat, Reinhard ^a   Jakesz, Raimund ^a   Birner, Peter ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CORRELATION ANALYSIS; DENSITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; LYMPH NODE; LYMPH VESSEL; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MACROPHAGES; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 33745165865     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2005.12.008     Document Type: Article

References (28)

1. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7 (2001) 192-198
2. Pepper M.S., Tille J.C., Nisato R., and Skobe M. Lymphangiogenesis and tumor metastasis. Cell Tissue Res 314 (2003) 167-177
3. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
4. Schoppmann S.F., Birner P., Stockl J., Kalt R., Ullrich R., Caucig C., et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161 (2002) 947-956
5. Jakesz R., Samonigg H., Gnant M., Kubista E., Depisch D., Kolb R., et al. Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group. Ann Surg 237 (2003) 556-564
6. Sobin L.H., Fleming I.D., and Union Internationale Contre le Cancer and the American Joint Committee on Cancer. TNM classification of malignant tumors, (1997). Cancer. 5th edition 80 (1997) 1803-1804
7. Elston E.W., and Ellis I.O. Method for grading breast cancer. J Clin Pathol 46 (1993) 189-190
8. Breiteneder-Geleff S., Soleiman A., Kowalski H., Horvat R., Amann G., Kriehuber E., et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries. podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154 (1999) 385-394
9. Horvat R., Hovorka A., Dekan G., Poczewski H., and Kerjaschki D. Endothelial cell membranes contain podocalyxin-the major sialoprotein of visceral glomerular epithelial cells. J Cell Biol 102 (1986) 484-491
10. Birner P., Oberhuber G., Stani J., Reithofer C., Samonigg H., Hausmaninger H., et al. Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. Clin Cancer Res 7 (2001) 1669-1675
11. Weidner N., Folkman J., Pozza F., Bevilacqua P., Allred E.N., Moore D.H., et al. Tumor angiogenesis. a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84 (1992) 1875-1887
12. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36 (1995) 169-180
13. Heimburg S., Oehler M.K., Papadopoulos T., Caffier H., Kristen P., and Dietl J. Prognostic relevance of the endothelial marker CD 34 in ovarian cancer. Anticancer Res 19 (1999) 2527-2529
14. Schoppmann S.F., Schindl M., Breiteneder-Geleff S., Soleima A., Breitenecker G., Karner B., et al. Inflammatory stromal reaction correlates with lymphatic microvessel density in early-stage cervical cancer. Anticancer Res 21 (2001) 3419-3423
15. Jakesz R., Dittrich C., Hanusch J., Kolb R., Lenzhofer R., Moser K., et al. Simultaneous and sequential determinations of steroid hormone receptors in human breast cancer. Influence of intervening therapy. Ann Surg 201 (1985) 305-310
16. Jakesz R., Hausmaninger H., Haider K., Kubista E., Samonigg H., Gnant M., et al. Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer. J Clin Oncol 17 (1999) 1701-1709
17. Kaplan E., and Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 53 (1985) 457-481
18. Schoppmann S.F., Birner P., Studer P., and Breiteneder-Geleff S. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res 21 (2001) 2351-2355
19. Schoppmann S.F., Bayer G., Aumayr K., Taucher S., Geleff S., Rudas M., et al. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240 (2004) 306-312
20. Padera T.P., Kadambi A., di Tomaso E., Carreira C.M., Brown E.B., Boucher Y., et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296 (2002) 1883-1886
21. Van der Auwera I., Van Laere S.J., Van den Eynden G.G., Benoy I., van Dam P., Colpaert C.G., et al. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clin Cancer Res 10 (2004) 7965-7971
22. Taichman N.S., Young S., Cruchley A.T., Taylor P., and Paleolog E. Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol 62 (1997) 397-400
23. Freeman M.R., Schneck F.X., Gagnon M.L., Corless C., Soker S., Niknejad K., et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor. a potential role for T cells in angiogenesis. Cancer Res 55 (1995) 4140-4145
24. He Y., Kozaki K., Karpanen T., Koshikawa K., Yla-Herttuala S., Takahashi T., et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94 (2002) 819-825
25. Cursiefen C., Chen L., Borges L.P., Jackson D., Cao J., Radziejewski C., et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113 (2004) 1040-1050
26. Hoar F.J., Chaudhri S., Wadley M.S., and Stonelake P.S. Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma. Eur J Cancer 39 (2003) 1698-1703
27. O-charoenrat P., Rhys-Evans P., Modjtahedi H., and Eccles S.A. Vascular endothelial growth factor family members are differentially regulated by c-erbB signaling in head and neck squamous carcinoma cells. Clin Exp Metastasis 18 (2000) 155-161
28. Tsai P.W., Shiah S.G., Lin M.T., Wu C.W., and Kuo M.L. Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem 278 (2003) 5750-5759